October 13th is Metastatic Breast Cancer Awareness Day!

This October 13th, during breast cancer awareness month, CCSN recognizes the unique experience of metastatic breast cancer patients. Approximately 30 percent of women and men diagnosed with breast cancer will at some point be diagnosed with metastatic breast cancer, and while metastatic breast cancer can be treated, it currently cannot be cured. This does not

Take part in CCSN’s important survey on Xgeva!

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of denosumab (Xgeva) for the prevention of skeletal-related events due to bone metastases from solid tumours. The information gathered from this survey will be used in order to prepare a patient evidence submission to